SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-14-002232
Filing Date
2014-10-27
Accepted
2014-10-27 09:20:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d07617007_10132014.htm SC 13D 108154
2 JOINT FILING AGREEMENT ex991to13d07617007_10132014.htm EX-99.1 7141
  Complete submission text file 0000921895-14-002232.txt   116898
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-246-6400
diaDexus, Inc. (Subject) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-56525 | Film No.: 141173645
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10451 MILL RUN CIRCLE SUITE 400 OWINGS MILLS MD 21117
Business Address 10451 MILL RUN CIRCLE SUITE 400 OWINGS MILLS MD 21117 410-654-3315
LEAP TIDE CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001540904 (see all company filings)

IRS No.: 274335176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D